Search Results

Therapy of Sézary syndrome

Authors: Kirby, Joslyn S; Kim, Ellen J; Rook, Alain H

Source: Expert Review of Dermatology, Volume 4, Number 6, December 2009 , pp. 567-579(13)

Publisher: Expert Reviews

Alemtuzumab in the reversal of encephalopathy associated with hypereosinophilic syndrome

Authors: Perini, Guilherme Fleury; Santos, Fábio P. S.; Hamerschlak, Nelson

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 592-592(1)

Publisher: Blackwell Publishing

Current and Emerging Treatments for Chronic Lymphocytic Leukaemia

Authors: Robak, Tadeusz; Jamroziak, Krzysztof; Robak, Pawel

Source: Drugs, Volume 69, Number 17, 3 December 2009 , pp. 2415-2449(35)

Publisher: Adis International

Monoclonal Antibodies in the Treatment of Multiple Sclerosis

Authors: Pauli, F. D.; Berger, T.; Reindl, M.

Source: Current Medicinal Chemistry, Volume 16, Number 36, December 2009 , pp. 4858-4868(11)

Publisher: Bentham Science Publishers

Alemtuzumab bei Multipler Sklerose: Vorläufige Ergebnisse und klinisches Entwicklungsprogramm

Author: Stemper, B.

Source: Der Nervenarzt, Volume 80, Supplement 1, July 2009 , pp. 62-63(2)

Publisher: Springer

Modern concepts in the treatment of chronic lymphocytic leukemia

Author: Smolej, Lukas

Source: Hematology, Volume 14, Number 5, October 2009 , pp. 249-254(6)

Publisher: Maney Publishing

Antineoplastics: EBV-positive large diffuse B cell non-Hodgkin's lymphoma: case report

Source: Reactions, Volume 1, Number 1271, 2009-09-26 , pp. 7-7(1)

Publisher: Adis International

Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti-thymocyte globulin

Authors: Park, S.H.; Choi, S.-M.; Lee, D.-G.; Choi, J.-H.; Yoo, J.-H.; Kim, S.-H.; Kim, H.-J.; Cho, S.-G.; Eom, K.-S.; Lee, J.-W.; Min, W.-S.; Shin, W.-S.; Kim, C.-C.

Source: Transplant Infectious Disease, Volume 11, Number 5, October 2009 , pp. 413-423(11)

Publisher: Blackwell Publishing

Cytomegalovirus (CMV) infections appear to be common in patients administered alemtuzumab

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 5-5(1)

Publisher: Adis International

Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis

Authors: Dalakas, Marinos C.; Rakocevic, Goran; Schmidt, Jens; Salajegheh, Mohammad; McElroy, Beverly; Harris-Love, Michael O.; Shrader, Joseph A.; Levy, Ellen W.; Dambrosia, James; Kampen, Robert L.; Bruno, David A.; Kirk, Allan D.

Source: Brain, Volume 132, Number 6, 30 June 2009 , pp. 1536-1544(9)

Publisher: Oxford University Press

Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death

Authors: Plata-Munoz, Juan J.; Vaidya, Anil; Fuggle, Susan V.; Friend, Peter J.

Source: Transplant International, Volume 22, Number 10, October 2009 , pp. 1024-1027(4)

Publisher: Blackwell Publishing

Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model

Authors: Hu, Yanping; Turner, Michael J.; Shields, Jacqueline; Gale, Matthew S.; Hutto, Elizabeth; Roberts, Bruce L.; Siders, William M.; Kaplan, Johanne M.

Source: Immunology, Volume 128, Number 2, October 2009 , pp. 260-270(11)

Publisher: Blackwell Publishing

Monoclonal antibody-induced cytokine-release syndrome

Authors: Bugelski, Peter J; Achuthanandam, Ram; Capocasale, Renold J; Treacy, George; Bouman-Thio, Esther

Source: Expert Review of Clinical Immunology, Volume 5, Number 5, September 2009 , pp. 499-521(23)

Publisher: Expert Reviews

Alemtuzumab: Coagulopathy: case report

Source: Reactions, Volume 1, Number 1263, 2009-08-01 , pp. 5-5(1)

Publisher: Adis International

Alemtuzumab: Fatal sepsis secondary to Cryptococcus neoformans infection in an elderly patient: case report

Source: Reactions, Volume 1, Number 1263, 2009-08-01 , pp. 5-5(1)

Publisher: Adis International

CD52 expression in peripheral T-cell lymphomas determined by combined immunophenotyping using tumor cell specific T-cell receptor antibodies

Authors: Geissinger, Eva; Bonzheim, Irina; Roth, Sabine; Rosenwald, Andreas; Muller-Hermelink, Hans Konrad; Rudiger, Thomas

Source: Leukemia and Lymphoma, Volume 50, Number 6, June 2009 , pp. 1010-1016(7)

Publisher: Informa Healthcare

BAFF Is Increased in Renal Transplant Patients Following Treatment with Alemtuzumab

Authors: Bloom, D.; Chang, Z.; Pauly, K.; Kwun, J.; Fechner, J.; Hayes, C.; Samaniego, M.; Knechtle, S.

Source: American Journal of Transplantation, Volume 9, Number 8, August 2009 , pp. 1835-1845(11)

Publisher: Blackwell Publishing

Ofatumumab for the treatment of chronic lymphocytic leukemia

Author: Robak, Tadeusz

Source: Therapy, Volume 6, Number 4, July 2009 , pp. 577-587(11)

Publisher: Future Medicine

Immunosuppressants: Human polyomavirus nephropathy: case report

Source: Reactions, Volume 1, Number 1255, 2009-06-06 , pp. 19-19(1)

Publisher: Adis International

Alemtuzumab: Cytomegalovirus retinitis: case report

Source: Reactions, Volume 1, Number 1253, 2009-05-23 , pp. 5-6(2)

Publisher: Adis International